KALV
KalVista Pharmaceuticals Inc.
$13.46
-$0.05(-0.37%)
37
Overall
--
Value
36
Tech
39
Quality
Market Cap
$657.39M
Volume
436.47K
52W Range
$7.30 - $16.32
Target Price
$31.67
EPS Estimates Overview
| Current Quarter | $-0.91 | Next Quarter | $-0.89 |
| Current Year | $-3.31 | Next Year | $-1.84 |
| QoQ Growth | +2.2% | YoY Growth | +44.4% |
| 3Y EPS CAGR | -2.4% | Target Price | $31.67 |
| Consensus | Buy | Upside | +135.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $13.46 | -0.4% | 436.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW